These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16333195)

  • 1. Leptospirosis vaccines: past, present, and future.
    Koizumi N; Watanabe H
    J Postgrad Med; 2005; 51(3):210-4. PubMed ID: 16333195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.
    Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK
    BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation.
    Murray GL; Lo M; Bulach DM; Srikram A; Seemann T; Quinsey NS; Sermswan RW; Allen A; Adler B
    Vaccine; 2013 Jan; 31(3):495-9. PubMed ID: 23176980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against leptospirosis.
    Adler B
    Curr Top Microbiol Immunol; 2015; 387():251-72. PubMed ID: 25388138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis.
    Gamberini M; Gómez RM; Atzingen MV; Martins EA; Vasconcellos SA; Romero EC; Leite LC; Ho PL; Nascimento AL
    FEMS Microbiol Lett; 2005 Mar; 244(2):305-13. PubMed ID: 15766783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF; Chen CS; Palaniappan RU; He H; McDonough SP; Barr SC; Yan W; Faisal SM; Pan MJ; Chang CF
    Vaccine; 2007 Nov; 25(48):8190-7. PubMed ID: 17936448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection.
    Garba B; Bahaman AR; Zakaria Z; Bejo SK; Mutalib AR; Bande F; Suleiman N
    Microb Pathog; 2018 Nov; 124():136-144. PubMed ID: 30138761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.
    Dellagostin OA; Grassmann AA; Rizzi C; Schuch RA; Jorge S; Oliveira TL; McBride AJ; Hartwig DD
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
    González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
    Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against leptospirosis: vaccine trials with heat-killed whole cell and outer envelope antigens in hamsters.
    Zeigler JA; Jones RH; Kubica K
    Bull Pan Am Health Organ; 1976; 10(2):126-30. PubMed ID: 974302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection among unrelated leptospira pathogens serovars: an unfinished story.
    Rosario LA; Arencibia DF; Suarez YE; Infante JF; Valdés BY; Batista N
    Adv Clin Exp Med; 2012; 21(5):581-9. PubMed ID: 23356194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the efficacy of Leptospira vaccines developed from serovars isolated from Trinidad and comparison with commercial vaccines using a hamster model.
    Suepaul SM; Carrington CV; Campbell M; Borde G; Adesiyun AA
    Vaccine; 2010 Jul; 28(33):5421-6. PubMed ID: 20598785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model.
    Lucas DS; Cullen PA; Lo M; Srikram A; Sermswan RW; Adler B
    Vaccine; 2011 Apr; 29(18):3413-8. PubMed ID: 21396409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system.
    Fraga TR; Barbosa AS; Isaac L
    Scand J Immunol; 2011 May; 73(5):408-19. PubMed ID: 21204903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous protection elicited by a live, attenuated, Leptospira vaccine.
    Murray GL; Simawaranon T; Kaewraemruaen C; Adler B; Sermswan RW
    Vet Microbiol; 2018 Sep; 223():47-50. PubMed ID: 30173751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis.
    Yan W; Faisal SM; McDonough SP; Chang CF; Pan MJ; Akey B; Chang YF
    Vaccine; 2010 Mar; 28(11):2277-83. PubMed ID: 20064477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptospiral immunoglobulin-like proteins elicit protective immunity.
    Koizumi N; Watanabe H
    Vaccine; 2004 Mar; 22(11-12):1545-52. PubMed ID: 15063580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant vaccines against leptospirosis.
    Dellagostin OA; Grassmann AA; Hartwig DD; Félix SR; da Silva ÉF; McBride AJ
    Hum Vaccin; 2011 Nov; 7(11):1215-24. PubMed ID: 22048111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.
    Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.